Stay updated on RC48-ADC in Low HER2 Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.

Latest updates to the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting was standardized. Footer metadata now includes Last verified and Last known status, and the site revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference1.0%

- Check18 days agoChange DetectedThe footer now shows Revision: v3.5.5, replacing the previous v3.5.4. This update signals a minor page revision without modifying the study details or navigation.SummaryDifference0.0%

- Check39 days agoChange DetectedA new Revision: v3.5.4 tag has been added, replacing the previous v3.5.3, indicating a minor update to the page version or template rather than to study data.SummaryDifference0.0%

- Check61 days agoChange Detected- The page footer revision/version was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check68 days agoChange DetectedFirst Hospital of China Medical University was added as a study site and First Affiliated Hospital of China Medical University was removed. The document revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to RC48-ADC in Low HER2 Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.